Browsing Category
Pharma Industry News
4730 posts
Business-News-Today.com section for global pharma industry news, Indian pharma sector latest news, pharma sector news today, pharmaceuticals industry news.
Capricor Therapeutics’ Deramiocel delivers pivotal Phase 3 HOPE-3 win in Duchenne muscular dystrophy study
Discover how Capricor Therapeutics’ Deramiocel achieved a pivotal Phase 3 win in Duchenne muscular dystrophy and what it means for patients and investors.
Can Genesis Molecular AI leap ahead in biotech with Meta’s Llama leader now onboard?
Genesis Molecular AI hires Meta's Llama leader Sergey Edunov to lead foundation models. Discover how this move strengthens its AI drug discovery platform.
Why U.S. based Trividia Health is gaining traction in blood glucose testing with TRUE METRIX
Trividia Health’s TRUE METRIX devices join Express Scripts’ preferred formulary. Discover how this U.S.-made glucose monitor is changing diabetes care access.
Inside the CVS whistleblower case that led to a $37.76m pharmacy fine
CVS Health agrees to pay $37.76M to settle insulin billing fraud claims. Find out what this means for drug pricing and pharmacy compliance in 2025.
Alpha Tau advances alpha DaRT with FDA approval for recurrent prostate cancer study
Find out how Alpha Tau’s FDA-approved prostate cancer trial could redefine localized salvage therapy and reshape treatment for recurrent disease.
Roche secures FDA clearance and CE Mark for rapid pertussis point-of-care diagnostic test
Discover how Roche’s FDA-cleared rapid pertussis test could transform point-of-care diagnosis and reshape decentralized molecular diagnostics worldwide.
Sangamo Therapeutics wins FDA fast-track status for gene therapy ST-503 targeting small fiber neuropathy
Find out how Sangamo Therapeutics’ FDA fast-track win for ST-503 could reshape small fiber neuropathy treatment and shift biotech investor sentiment.
Polyrizon achieves major production milestone for PL-14 nasal spray as 2026 clinical trial preparation accelerates
Polyrizon has successfully scaled production of its PL-14 intranasal hydrogel to clinical-trial grade, clearing a critical hurdle ahead of its planned 2026 human study.
From rare disease to mass market: plozasiran gets FDA green light for severe hypertriglyceridemia review
Arrowhead’s plozasiran receives FDA Breakthrough Therapy status for severe hypertriglyceridemia. Learn what this means for trials, patients, and the RNAi market.
Briquilimab shows promising asthma signal in ETESIAN study as Jasper Therapeutics resolves BEACON probe
Discover how Jasper Therapeutics reignited confidence in briquilimab with new asthma data and a clarified BEACON investigation.